Placeholder while article actions loadPfizer and its German partner, BioNTech, on Wednesday finished submitting an application for regulatory authorization of a coronavirus vaccine for children younger than 5. The news comes a week after Pfizer-BioNTech announced that three shots of its low-dose pediatric vaccine triggered a robust immune response in young children and was safe. “We recognize parents are anxious to have their young children vaccinated against COVID-19,” FDA spokeswoman Abigail Capobianco wrote in an email. The agency is expected to act quickly, meaning young children could get their first shots this month. In lab tests, Moderna’s two-shot regimen triggered a strong immune response in young children.

Source: Washington Post June 02, 2022 07:57 UTC